Exchange: OTC·Updated 12:12 PM EDT
About MGCLD
Argent BioPharma Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of nano-engineered therapeutics targeting neurological and immune-mediated disorders. It operates through the following geographical segments: Malta, Slovenia, United Kingdom (UK), and Australia. The company was founded by Roby Zomer on October 21, 2005 and is headquartered in Subiaco, Australia.